The Hazer Commercial Demonstration Project (CDP) being constructed at Water Corporation’s Woodman Point Water Recovery Facility. Source: Hazer Group/Facebook
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Hazer Group’s (HZR) commissioning of its commercial demonstration project in Western Australia has been delayed due to a manufacturing flaw
  • The company has been advised that the reactor vessel currently awaiting heat treatment in China has a defect and is consequently unsuitable
  • Work is being undertaken to to determine a rectification plan to mitigate impacts on budget and schedule
  • CEO Geoff Ward says planned activities are continuing which will allow cold commissions and testing of the plant prior to delivery and installation of the reactor
  • Shares have been trading 13.1 per cent lower at $1.07

Hazer Group’s (HZR) planned commissioning of its commercial demonstration project in Western Australia has been delayed.

In September, HZR said progress had been made in the engineering, fabrication and construction of the 100 tonnes per annum, low-emission hydrogen production facility which is located at the Water Corporation’s Woodman Point wastewater treatment plant.

However, the company has since been advised that a manufacturing flaw has been identified in the Hazer reactor vessel currently waiting for heat treatment in China.

Quality assurance and non-destructive testing activities confirmed the presence of the manufacturing flaw and identified further areas of concern.

As a result of the flaw identified, the reactor shell has been deemed unsuitable and will require remedial manufacturing actions before it can be certified and accepted for dispatch.

Chief Executive Officer Geoff Ward said the set back so far into the company’s construction schedule was deeply disappointing.

He said work will now be undertaken to identify the causes of the issue and implement any actions available to mitigate the impact on the project budget and schedule.

The commissioning target date was the first quarter of 2022 however this will be pushed back.

The CEO said all planned activities are continuing which will allow cold commissioning and testing of the plant, including catalyst handling, fluidisation and control systems, prior to the delivery and installation of the reactor.

Shares were trading 13.1 per cent lower at $1.07 at 11:25 am AEDT.

HZR by the numbers
More From The Market Online
The Market Online Video

Market Update: ASX on red alert with all sectors below the surface

The ASX200 is trading down around 1.1% with all eleven sectors in the red. Real-estate has…

ResMed spikes on robust results and global growth spurt

ResMed shares have climbed following the release of the company's strong Third Quarter FY2024 results.

Winter drilling yields thick lithium for Loyal in Canada

Loyal Lithium has picked up multiple high-grade results close to the surface from three known spodumene…

Trinex Minerals had a hot winter on high grade Uranium hits in Canada

Trinex Minerals has intercepted high grade uranium at the Gibbons Creek Uranium Project in Canada after…